CELEX: 62017TN0103
Language: en
Date: 2017-02-17 00:00:00
Title: Case T-103/17: Action brought on 17 February 2017 — Recordati Orphan Drugs v EUIPO — Laboratorios Normon (NORMOSANG)

18.4.2017   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 121/41
            
         Action brought on 17 February 2017 — Recordati Orphan Drugs v EUIPO — Laboratorios Normon (NORMOSANG)
   (Case T-103/17)
   (2017/C 121/60)
   Language in which the application was lodged: English
   
      Parties
   
   
      Applicant: Recordati Orphan Drugs (Puteaux, France) (represented by: J. Quirin, lawyer)
   
      Defendant: European Union Intellectual Property Office (EUIPO)
   
      Other party to the proceedings before the Board of Appeal: Laboratorios Normon SA (Tres Cantos, Spain)
   
      Details of the proceedings before EUIPO
   
   
      Applicant of the trade mark at issue: Applicant
   
      Trade mark at issue: EU word mark ‘NORMOSANG’ — Application for registration No 12 174 926
   
      Procedure before EUIPO: Opposition proceedings
   
      Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 22 November 2016 in Case R 831/2016-5
   
      Form of order sought
   
   The applicant claims that the Court should:
   
               —
            
            
               annul the contested decision;
            
         
               —
            
            
               order EUIPO to pay the costs.
            
         
      Pleas in law
   
   
               —
            
            
               Infringement of Article 8(1)(b) of Regulation No 207/2009;
            
         
               —
            
            
               Infringement of Rules 19(2)(a)(ii) and 20(1) of Regulation No 2868/95.